Associations of sarcopenic obesity versus sarcopenia alone with functionality
- PMID: 33940398
- DOI: 10.1016/j.clnu.2021.04.002
Associations of sarcopenic obesity versus sarcopenia alone with functionality
Abstract
Background & aims: There have been several attempts to come up with a global operational definition of sarcopenia (S), and consequently, a definition of S has been established, to some extent. That said, the definition of sarcopenic obesity (SO), which is defined as the presence of obesity + sarcopenia, remains obscure, hindering evaluations of the prevalence and relevance of SO. It has yet to be elucidated whether SO is associated with worse functionality when compared to S alone (S without obesity). In the present study, we compare SO and S alone in terms of their associations with functional measures through the application of alternative definitions of SO. As a secondary output, we document the prevalence of SO based on alternative definitions.
Methods: This retrospective cross-sectional study included community-dwelling adults over 60 years of age who presented as outpatients to a university hospital between 2012 and 2020. All were evaluated for body composition (bioimpedance analysis), handgrip strength (Jamar hand dynamometer) and functional health status [activities of daily living (ADL), instrumental activities of daily living (IADL)]. The fat percentile method was used to define the obesity component of SO. Low muscle mass (LMM) was defined using two different adjustment methods of skeletal muscle mass (LMM adjusted by height2 or LMM adjusted by BMI). S was defined based on the EWGSOP2 definition, as probable S (low muscle strength) or confirmed S (low muscle strength + LMM). Accordingly, three alternative definitions of SO were applied based on three alternative definitions of S, i.e., "obesity + sarcopenia (probable)", "obesity + sarcopenia (confirmed, LMM adjusted by height2)" and "obesity + sarcopenia (confirmed, LMM adjusted by BMI)". The associations of SO and S alone with functional measures were examined with univariate analyses and adjusted multivariate analyses.
Results: Included in the study were 1468 older adults (median age 75; 68.8% female). The prevalence of SO was very low (0.2%) based on the SO definition "obesity + sarcopenia (confirmed, LMM adjusted by height2), but it was present at a considerable and comparable rate based on SO definition "obesity + sarcopenia (probable)" and SO definition "obesity + sarcopenia (confirmed, LMM adjusted by BMI)" (4.1%, 4.0%; respectively). As SO by "obesity + sarcopenia (confirmed, LMM adjusted by height2)" had an ignorable prevalence, this definition of SO was excluded from further analyses. Multivariate analyses revealed that, when compared to the Non-S Non-Obese group, S alone definitions had odds ratio (OR) of 5.4 and 3.4 while SO definitions had an OR of 3.2 and 2.7 for impaired ADL, and an OR of 7.9 and 6.4, while SO definitions had an OR of 3.0 and 2.7 for impaired IADL. SO was thus found to be associated with a lower prevalence of impaired functional measures than that of S alone.
Conclusions: Our results suggest that the SO definition confirmed, LMM adjusted by height2 has an ignorable prevalence in populations in which underweight or malnutrition is uncommon. Among sarcopenic older individuals, obesity may have a protective effect against the limitations of some functional measures, providing evidence of the possible protective effect of obesity in sarcopenic individuals.
Keywords: Definition; EWGSOP2; Fat percentile; Functionality; Sarcopenia; Sarcopenic obesity.
Copyright © 2021 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Conflict of interest statement
Conflict of interest There are no other relationships/conditions/circumstances that may represent a potential conflict of interest.
Similar articles
-
Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.Clin Nutr. 2023 Sep;42(9):1610-1618. doi: 10.1016/j.clnu.2023.07.014. Epub 2023 Jul 17. Clin Nutr. 2023. PMID: 37481869
-
Sarcopenic obesity versus sarcopenia alone with the use of probable sarcopenia definition for sarcopenia: Associations with frailty and physical performance.Clin Nutr. 2022 Nov;41(11):2509-2516. doi: 10.1016/j.clnu.2022.09.005. Epub 2022 Sep 15. Clin Nutr. 2022. PMID: 36219979
-
Prevalence of sarcopenia and its components in community-dwelling outpatient older adults and their relation with functionality.Aging Male. 2020 Dec;23(5):424-430. doi: 10.1080/13685538.2018.1511976. Epub 2018 Oct 5. Aging Male. 2020. PMID: 30290756
-
An Overview of Sarcopenic Obesity.J Clin Densitom. 2015 Oct-Dec;18(4):499-505. doi: 10.1016/j.jocd.2015.04.013. Epub 2015 Jul 2. J Clin Densitom. 2015. PMID: 26141163 Review.
-
Impact of EASO/ESPEN-Defined Sarcopenic Obesity Following a Technology-Based Weight Loss Intervention.Calcif Tissue Int. 2024 Jan;114(1):60-73. doi: 10.1007/s00223-023-01138-4. Epub 2023 Sep 27. Calcif Tissue Int. 2024. PMID: 37758867 Review.
Cited by
-
Sarcopenic obesity in older adults: a clinical overview.Nat Rev Endocrinol. 2024 Feb 6. doi: 10.1038/s41574-023-00943-z. Online ahead of print. Nat Rev Endocrinol. 2024. PMID: 38321142 Review.
-
Relationship between Lean Tissue Mass and Muscle Function in Women with Obesity.Nutrients. 2023 Oct 25;15(21):4517. doi: 10.3390/nu15214517. Nutrients. 2023. PMID: 37960170 Free PMC article.
-
Assessing quality of life with SarQol is useful in screening for sarcopenia and sarcopenic obesity in older women.Aging Clin Exp Res. 2023 Oct;35(10):2069-2079. doi: 10.1007/s40520-023-02488-7. Epub 2023 Jul 13. Aging Clin Exp Res. 2023. PMID: 37442906 Free PMC article.
-
Alternative skeletal muscle index for sarcopenia diagnosis in elderly patients with type 2 diabetes mellitus: A pilot study.Front Endocrinol (Lausanne). 2023 Feb 9;14:1083722. doi: 10.3389/fendo.2023.1083722. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36843587 Free PMC article.
-
Recent Updates on Associations among Various Obesity Metrics and Cognitive Impairment: from Body Mass Index to Sarcopenic Obesity.J Obes Metab Syndr. 2022 Dec 30;31(4):287-295. doi: 10.7570/jomes22058. Epub 2022 Dec 19. J Obes Metab Syndr. 2022. PMID: 36530066 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
